VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018)
VitaNova Life Sciences' (VNOV) quarterly Total Non-Current Liabilities came in at $12600.0 in Q3 2018, up 125.0% on a QoQ basis from $5600.0 in Q2 2018.
VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018) Analysis & Trends
VitaNova Life Sciences (VNOV) has 2 years of Total Non-Current Liabilities data on file, last reported at $12600.0 in Q3 2018.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $12600.0 in Q3 2018, while the trailing twelve-month figure through Jul 2018 was $12600.0 (changed N/A YoY) and the FY2018 annual result came in at $5600.0, down 51.72% from the prior year.
- Total Non-Current Liabilities grew to $12600.0 in Q3 2018, from $5600.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $12600.0 in Q3 2018 to a low of $5600.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 83.27 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -2.92 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 6.22 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 2,565.00 |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 75.80 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.45 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 251.86 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 38.31 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | 12,600.00 |
| Apr 30, 2018 | 5,600.00 |
| Jan 31, 2018 | 5,600.00 |
| Oct 31, 2017 | 5,600.00 |
| Apr 30, 2017 | 11,600.00 |